Atlas Trials

GSK1120212 Rollover Study

Clinical trial NCT01376310 · TERMINATED

Trial details

NCT number
NCT01376310
Sponsor
Novartis Pharmaceuticals
Status
TERMINATED
Phase
Phase 2
Study type
INTERVENTIONAL
Cancer
Start date
2010-11-02
Primary completion
2018-01-18
Enrollment
159

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.